| 
		 
		Special Report: How Monsanto's GM cotton 
		sowed trouble in Africa 
		
		 
		Send a link to a friend  
 
		
		
		 [December 08, 2017] 
		By Joe Bavier 
		 
		BOBO-DIOULASSO, Burkina Faso (Reuters) - In 
		2000, farmers in Burkina Faso, Africa's top cotton grower, were 
		desperate. Their cotton fetched top prices because its high-quality 
		fiber lent a luxurious sheen to clothing and bedsheets. But pests – 
		bollworms – were threatening the crop. 
		 
		Even when you dropped the bollworm larvae into a bucket of poison, 
		farmers said, they kept swimming. 
		 
		U.S. seeds and pesticide company Monsanto proposed an answer: a 
		genetically modified strain of cotton called Bollgard II, which it had 
		already introduced in America and was marketing worldwide. GM was 
		established in large-scale farming in South Africa, but not among the 
		smallholders who produce most African cotton. The Burkina farmers agreed 
		to a trial and the country introduced seeds with the gene in 2008. 
		 
		The resulting cotton was pest-free, and the harvest more abundant. By 
		2015, three-quarters of all Burkina Faso's production was GM, and it 
		became a showcase for the technology among smallholders in Africa. From 
		2007 to 2015, delegations from at least 17 different African nations 
		visited Burkina to see it. 
		
		
		  
		
		But there was a problem. While the bug-resistant genes produced more 
		volume, the quality fell. Last season, the cotton farmers of Burkina 
		Faso abandoned the GM varieties. 
		 
		"Genetically modified cotton, it's not good today. It's not good 
		tomorrow," said farmer Paul Badoun, picking apart a lumpy handful of raw 
		cotton in his field near Kongolekan, a village of small mud brick houses 
		in the southwestern cotton heartland. 
		 
		The country's GM experience, told by more than three dozen Monsanto 
		insiders, farmers, scientists and cotton company officials as well as in 
		confidential documents reviewed by Reuters, highlights a little-known 
		quandary faced by genetic engineering. For Burkina Faso's cotton 
		growers, GM ended up as a trade-off between quantity and quality. For 
		Monsanto, whose $13.5 billion in revenues in 2016 were more than Burkina 
		Faso's GDP, it proved uneconomical to tailor the product closely to a 
		market niche. 
		 
		The Burkinabes knew from the start that American cotton varieties 
		containing Monsanto's gene could not deliver the quality of their 
		home-grown crop, cotton company officials and researchers told Reuters. 
		But they pressed on because Monsanto agreed to breed its pest-resistant 
		genes into their native plants, which they hoped would protect the 
		cotton and keep its premium value. That, they say, was a failure. 
		 
		In July 2015 Monsanto wrote to the Burkina growers saying the quality 
		problems had been offset by other benefits. Asked by Reuters about the 
		quality problems and whether it promised to fix them, the company did 
		not respond. Instead, it pointed to a dispute that erupted with Burkina 
		Faso over payments for seed-licensing fees. 
		 
		"We exited our cotton business in Burkina Faso due to the increasing 
		challenge in collecting license fees that had remained due for a 
		significant period, despite Monsanto's efforts to explore pragmatic 
		solutions," the company said in an emailed response to Reuters' queries. 
		 
		The company, which has agreed to a $66 billion takeover by Germany's 
		Bayer, told Reuters its genetic traits transformed Burkina Faso's cotton 
		sector, improving the lives of 350,000 farmers and the roughly 4 million 
		Burkinabes who depend on them, by increasing production and reducing 
		pesticide use. 
		
		
		  
		
		Roger Zangre, a Burkinabe agricultural scientist who helped bring 
		Monsanto to Burkina Faso, said Burkina's technical shortcomings were 
		partly to blame for the problems with the GM crops. "Before the 
		introduction, our capacities should have been reinforced. But all of 
		that fell by the wayside, and that's on us ... We can't blame Monsanto 
		alone," said Zangre, who was employed by the state and said he had never 
		been paid by Monsanto. 
		 
		But Brian Dowd-Uribe, an assistant professor at the University of San 
		Francisco who has studied the case, said the Burkinabe experience has 
		undermined confidence in Monsanto. He and five other international and 
		Burkinabe researchers and cotton sector officials believe Burkina's 
		quality problem boiled down to poor breeding processes. 
		 
		"Here is an issue that was established early on in the breeding process 
		and trial stage that over almost 10 years they were unable to resolve," 
		he said. "What does that mean in terms of Monsanto's ability to 
		successfully steward breeding programs that allow for the ... 
		characteristics desired by their partners?" 
		 
		Monsanto declined to comment on this. It said its Bollgard II technology 
		remains under consideration in several countries in sub-Saharan Africa 
		and is showing good results in trials in Malawi. Authorities in Malawi 
		did not respond to requests for comment. 
		 
		Africa's annual cotton exports are worth nearly $1.2 billion, according 
		to statistics compiled by the Swiss-based International Trade Centre. 
		South Africa and Sudan are the only other African nations apart from 
		Burkina Faso to introduce GM cotton so far. Sudan opted to introduce 
		foreign varieties that it knew would produce lower quality cotton, 
		calculating that the increased output would offset the drop in value, a 
		cotton expert at Sudan's agriculture ministry said. For now, he added, 
		that bet has paid off. 
		 
		In Ghana, Uganda and Nigeria, growers have also been testing Bollgard 
		II, but they say Burkina Faso's experience has made them more cautious. 
		"We are being very skeptical now," said James Wiyor, executive secretary 
		of Ghana's Cotton Development Authority. 
		 
		Mali, Africa's number two producer and Burkina Faso's main local rival, 
		says it stuck with conventional, high-quality strains; it says this 
		decision gave it an edge over its GM rivals. 
		
		
		  
		
		"It's a shame," said Jane Dever, a professor and cotton breeder at Texas 
		A&M University, discussing Burkina Faso's experience, "because (Burkina 
		Faso) really was (Monsanto's) guinea pig for introducing transgenic 
		cotton into West Africa." 
		 
		"EVERYTHING WAS GOOD" 
		 
		Burkina Faso is big in African cotton, but small in global terms. India, 
		the world leader, grows over 20 times more cotton each year. Even so, 
		Burkina depends heavily on cotton exports. 
		 
		Around a fifth of its workforce participates in the sector, according to 
		the World Bank. Unable to go head-to-head against big producers, Burkina 
		Faso instead cultivated quality. 
		 
		"Burkina cotton was one of the most preferred cottons," said Ashwin 
		Subramanian, head of Singapore-based commodities trader Olam 
		International's West African cotton business. "The importing countries 
		in the Far East always preferred Burkina cotton. The quality was good. 
		The consistency was good. Everything was good." 
		 
		The country's major pest problems began in the 1990s - first whiteflies, 
		then bollworms which feed on flower buds, withering them and damaging 
		fruits. 
		 
		Farmers were spending around $60 million every year to protect their 
		cotton, and even then losing 20 percent to 65 percent of their crops, 
		Monsanto told Reuters. Losses could rise to 90 percent in fields that 
		had not been treated with pesticides. 
		 
		In 1995, the Burkina government asked Zangre, the local agricultural 
		scientist, to look into biotech solutions. He met Monsanto officials at 
		a conference in Cameroon in 1999 and the following year helped introduce 
		the company's representatives to officials from Burkina's cotton 
		companies and the farmers' union. Together with government officials, 
		they decide policy for the cotton sector. 
		 
		In 2003, Burkinabe researchers began testing Bollgard II cotton that was 
		being grown in the United States. Right away, they confirmed it was 
		effective against pests. It contains a bacterium called Bacillus 
		thuringiensis, or Bt, that wards off insect larvae. 
		
		
		  
		
		But the quality problems were equally obvious. 
		 
		Cotton quality is most commonly determined by the length of the fiber, 
		or staple, that emerges when a tuft is pulled out of a cotton boll. The 
		longer the fiber or staple, the higher the quality. Monsanto's American 
		Bt cotton produced short fibers, the kind typically used to make fabric 
		for everyday use such as jeans and t-shirts. 
		 
		"When we started using it, we knew that the American variety wouldn't 
		interest us, because it didn't have the quality we required," said 
		Bazoumana Koulibaly, research head for the cotton program at Burkina 
		Faso's agricultural research institute, INERA. 
		 
		The Burkinabes said they asked Monsanto to breed the Bt gene into their 
		native cotton, so they could marry its pest resistance with their long 
		fibers. However, tests conducted by INERA in 2006 and 2008 found that 
		the new Burkinabe Bt fibers were between 0.88 mm and 2.41 mm shorter 
		than the country's conventional cotton. 
		 
		[to top of second column] 
			 | 
            
             
            
			  
            
			Farmers work at a cotton market in Soungalodaga village near 
			Bobo-Dioulasso, Burkina Faso March 8, 2017. Picture taken March 8, 
			2017. REUTERS/Luc Gnago 
            
			  
            In 2008, Burkina Faso's government tried to introduce new liability 
			provisions to the deal, according to a U.S. diplomatic cable 
			published by WikiLeaks. Then U.S. Ambassador Jeanine Jackson 
			intervened on behalf of Monsanto. 
			 
			"Upon hearing the news of a possible halt to the planned 
			commercialisation of the Bt cotton in Burkina Faso, Ambassador 
			discussed the issues with both Prime Minister Tertius Zongo and 
			Monsanto reps," the cable said. "The PM then interceded and 
			instructed that the administrative order be changed to meet 
			Monsanto's terms." 
			 
			The Burkinabes initially wanted to commit Monsanto to compensating 
			the cotton company and its associates if there were problems, 
			according to a memo the cotton industry sent to Monsanto which was 
			reviewed by Reuters. The revised administrative order said instead 
			disputes should be handled through legal and regulatory channels and 
			resolved in good faith. 
            Zongo declined to comment on why he interceded. Jackson, who has now 
			retired from diplomatic service, said she did not recall the details 
			but noted that advocacy of U.S. businesses and investments is 
			usually the "number one task" for ambassadors. Monsanto did not 
			respond to a request for comment on this point. 
			 
			Burkina introduced the new GM cotton for seed production in the 
			2008-2009 season. A full-scale commercial launch was scheduled for 
			the following season. 
			 
			Wilfried Yameogo, the director of Sofitex, Burkina Faso's biggest 
			cotton company, said the decision to go ahead was based on a pledge 
			from Monsanto that it would fix the quality problems ahead of the 
			commercial launch. 
			 
			"Monsanto made promises, and we continued to produce it. They said, 
			'No, no, no. It will be okay.'" Yameogo said. Reuters could not 
			confirm whether such a promise was made and Monsanto did not respond 
			to a request for comment on this. 
			 
			SHORT FIBERS 
			 
			The growers moved fast. By 2014, GM cotton had surged to almost 
			three-quarters of all the cotton acreage planted in Burkina Faso. 
              
			In the three seasons before Burkina introduced Bt cotton, over 90 
			percent of its output was classed as high quality medium to long 
			staple by the country's cotton companies. In 2010-2011, GM cotton 
			made up over half of production, but only 21 percent of the crop 
			reached the previous quality standard. 
			 
			"There was a problem selling this cotton," Agriculture Minister 
			Jacob Ouedraogo told Reuters. 
			 
			Monsanto paid nearly $3 million in compensation to the Burkinabes in 
			those first two seasons due to the quality problems, according to 
			the memo reviewed by Reuters, which was sent in 2015 to complain 
			about losses cotton companies had incurred. Monsanto declined to 
			comment on this point. 
			 
			Burkina Faso's cotton continued to suffer. In 2014-2015, average Bt 
			cotton fibers from around the country were up to 2.29 mm shorter 
			than the conventional strains. The cotton lost its premium pricing. 
			The impact, according to the Burkinabes, was a drop in the value of 
			its output of at least 3 cents per pound of cotton, or between 2 and 
			5 percent of the volatile global benchmark price. 
			 
			Singapore trader Olam International had been among Burkina Faso's 
			biggest customers. It had to seek out new buyers, eventually selling 
			on the cheaper output to textile mills in Pakistan, said Olam's West 
			Africa cotton chief Subramanian. 
			 
			KNOW-HOW 
			 
			Geneticists like Dever say the problem was the process, not the Bt 
			gene. Retaining specific quality characteristics in new varieties is 
			one of the hardest tasks facing cotton breeders, Dever said. 
			 
			"It can be done," she said. "You just have to make sure you do the 
			appropriate number of backcrosses and you do the appropriate amount 
			of testing." 
			 
			To introduce a gene, breeders cross a plant already containing it 
			with a second parent possessing other desired traits - in this case, 
			Burkina's long cotton fibers. They then breed the first hybrid with 
			the second parent. The process, known as a backcross, continues: The 
			more backcrosses, the more the new variety will resemble the second 
			parent. 
			 
			Zangre and INERA'S Koulibaly said Monsanto carried out just two 
			backcrosses before introducing the new variety. "Evidently the two 
			backcrosses were insufficient. It was necessary to go further. 
			Breeders will go to six or seven backcrosses to really get over 99 
			percent purity," Koulibaly said. Monsanto declined to comment on 
			this. 
            
			  
			Dever, who has developed cotton varieties for companies including 
			Bayer, estimated that carrying out three more backcrosses would have 
			pushed back the release date of Bt cotton by at least a year. 
			 
			Zangre said that if the Burkinabes had possessed the proper tools 
			and technical knowledge to introduce the Bt genes themselves, they 
			could have avoided the mistake. 
			 
			Yves Carrière, an entomology professor at the University of Arizona 
			who studies Bt crops, arrived in Burkina Faso in 2009 planning to 
			set up a program to monitor the introduction. He was worried, he 
			said: The Burkina authorities had plans to head off potential 
			problems, but the universities and state agencies that in the 
			developed world would typically support such a biotechnology launch 
			appeared weak. 
			 
			"It was rushed. That's for sure ... It was rushed and far from 
			optimal," he said. "It shows the shortcomings of even the largest 
			corporations, which do not have the structure and the means to do 
			everything that needs to be done in developing countries." 
			 
			For its part, Monsanto never based technical staff in the country, a 
			former Monsanto employee who was involved in the process told 
			Reuters. Instead, he said Monsanto developed the new Bt varieties in 
			the United States, paid around $350,000 annually to fund research 
			institute INERA's work on the GM cotton, and flew in its own 
			scientists when required. 
			 
			Monsanto declined to say if it had based its own researchers in 
			Burkina Faso, but said its activities resulted in significant 
			investments in research and development. 
            
			  
			"ARMED AND SEASONED" 
			 
			By 2016, the Inter-Professional Cotton Association of Burkina 
			(AICB), the cotton sector's umbrella organization, claimed the 
			cotton companies' losses had reached around $85 million over the 
			previous five seasons. 
			 
			In the final settlement that ended the partnership last December, 
			Yameogo said Monsanto ceded over $19 million in royalties that the 
			Burkinabes had been withholding. In exchange, the Burkinabes agreed 
			to drop demands for compensation. Monsanto said the settlement, 
			which it called a "goodwill gesture," was confidential. 
			 
			For Burkina Faso's farmers, Bt cotton's benefits were "barely 
			acceptable," according to a 2016 study by the French government's 
			agricultural research agency, CIRAD. It found farmers made more 
			money, but the new seeds also increased their financial risk. 
			 
			Burkina Faso is now clawing back its reputation. In the 2016-2017 
			season, the first since it returned to conventional cotton seeds, 
			98.8 percent of its production was graded as medium to long staple. 
			So far, the bollworms have not returned. 
			 
			If they do, Burkinabe officials say they aren't turning their backs 
			on GM, although the country does not use the technology at present. 
			However, they say, any varieties must fit their unique needs. 
			 
			"We still favor the use of biotechnologies," said Yameogo, the 
			cotton company boss. "We've been armed and seasoned by the 
			experience we had with Monsanto." 
			 
			(Reporting by Joe Bavier in Bobo-Dioulasso; Additional reporting by 
			Nadoun Coulibaly in Ouagadougou, Khalid Abdelaziz in Khartoum, Arwa 
			Gaballa in Cairo, Tiemoko Diallo in Bamako, Kwasi Kpodo in Accra, 
			Elias Biryabarema in Kampala, Mabvuto Banda in Lilongwe, and Alexis 
			Akwagyiram in Lagos; Edited by Sara Ledwith) 
		[© 2017 Thomson Reuters. All rights 
			reserved.] 
			Copyright 2017 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			   |